ComputChem is a technology company focused on in silico covalent drug discovery design and lead optimization within the clean energy sector. The company aims to translate computational chemistry research into innovative drug discovery solutions. As a portfolio company of Early Charm Drug Design, ComputChem has received its latest grant investment from the Maryland Innovation Initiative (MII) on 29 March 2023. Based in the United States, ComputChem demonstrates potential for advancements in the intersection of computational chemistry and drug discovery, attracting attention from investors and researchers alike.
General Information
Get notified when ComputChem moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ComputChem
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Clean Energy
About ComputChem
Taxonomy: Computational Chemistry, Drug Discovery, In Silico, Covalent Drug Design, Lead Optimization, Technology Company, Platform Solutions, Early Charm Drug Design, Innovation, Chemical Research, Pharmaceuticals, Technology Innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 29 Mar 2023 |
ComputChem Alternatives & Competitors
Addressing urgent unmet medical needs through deeper science, true originality, and rich experience....
Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments.
Pioneering excellence in drug design and discovery since 2001.
FAQ About ComputChem
Don't just browse. Track.
Signal Tracker monitors ComputChem and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.